SAN DIEGO, July 13, 2016 /PRNewswire/ -- Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by Avinger, Inc. (NASDAQ: AVGR). Avinger is a commercial-stage medical device company that designs, manufactures and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD).
Specifically, Johnson & Weaver's investigation seeks to determine whether certain statements regarding the Company's business and prospects were false and misleading when made.
On July 12, 2013, Avinger announced that it expects total revenue of $4.7 million for the second quarter ended June 30, 2016 vs. the consensus estimate of $5.70 million. The Company now expects 2016 revenue to be in the range of $19 million to $23 million, compared to previous guidance for revenue in the range of $25 million to $30 million.
If you are an Avinger shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker ([email protected]) at 619-814-4471. If you email, please include your phone number.
About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.